TY - JOUR AB - Following the publication of this paper, it was drawn to the Editors’ attention by a concerned reader that certain of the western blotting data shown in Fig. 3C, 4D, 5A and 6D bore unexpected similarities to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in Oncology Reports 34: 3272‑3279, 2015; DOI: 10.3892/or.2015.4321] AD - Department of Pediatric Gastroenterology, The First Hospital, jilin University, Changchun, jilin 130021, P.R. China The Experiment Center, College of Basic Medical Sciences, jilin University, Changchun, jilin 130021, P.R. China Department of Hepatology, The First Hospital, jilin University, Changchun, jilin 130021, P.R. China AU - Pang,Xiaoli AU - Huang,Kexin AU - Zhang,Qianqian AU - Zhang,Yujiao AU - Niu,Junqi DA - 2021/08/01 DO - 10.3892/or.2021.8113 IS - 2 JO - Oncol Rep KW - hepatocellular carcinoma miR-154 ZEB2 tumor suppressor PY - 2021 SN - 1021-335X 1791-2431 SP - 161 ST - [Retracted] miR‑154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor T2 - Oncology Reports TI - [Retracted] miR‑154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor UR - https://doi.org/10.3892/or.2021.8113 VL - 46 ER -